7 épisodes

The European Society of Cardiology brings you the most relevant news in cardiovascular medicine, opinions from leading experts, and insight into the latest developments in our field that really matter.

You can also be interested in other ESC podcasts: ESC Cardio Talk, EHRA Cardio Talk and HFA Cardio Talk. Check them out!

ESC TV Today – Your Cardiovascular News European Society of Cardiology

    • Forme et santé

The European Society of Cardiology brings you the most relevant news in cardiovascular medicine, opinions from leading experts, and insight into the latest developments in our field that really matter.

You can also be interested in other ESC podcasts: ESC Cardio Talk, EHRA Cardio Talk and HFA Cardio Talk. Check them out!

    Among the topics: The latest on Patent Foramen Ovale (PFO) closure - Spontaneous Coronary Artery Dissection (SCAD)

    Among the topics: The latest on Patent Foramen Ovale (PFO) closure - Spontaneous Coronary Artery Dissection (SCAD)

    ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
    This episode covers:
    Cardiology This Week: A concise summary of recent studies Update on indications and methods for Patent Foramen Ovale (PFO) closure Incidence, outcome, acute and chronic treatment of Spontaneous Coronary Artery Dissection (SCAD) Mythbusters: The earlobe crease Host: Rick Grobbee
    Guests: Carlos Aguiar, Lorenz Raeber and Jacqueline Saw
    Want to watch that episode? Go to: https://esc365.escardio.org/event/802
    Disclaimer:
    This programme is intended for health care professionals only and is to be used for educational purposes.
    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
    Declarations of interests
    Stephan Achenbach, Rick Grobbee, Nicolle Kraenkel and Jacqueline Saw declared to have no potential conflict of interest to report.
    Carlos Aguiar declared to have potential conflict of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
    Davide Capodanno declared to have potential conflict of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.
    Lorenz Raeber declared to have potential conflicts of interest to report: Consultation/speaker fees from Abbott, Amgen, AstraZeneca, Canon, Medtronic, Novo Nordisk, Occlutech, Sanofi. Research grants to the institution by Abbott, Biotronik, Heartflow, Sanofi, Regeneron.
    Emma Svennberg declared to have potential conflict of interest to report: Institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

    • 20 min
    Among the topics: Iron deficiency in heart failure – Cardiovascular management of patients undergoing non-cardiac surgery

    Among the topics: Iron deficiency in heart failure – Cardiovascular management of patients undergoing non-cardiac surgery

    ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
    This episode covers:
    Cardiology This Week: A concise summary of recent studies The IRONMAN trial and the role of iron deficiency in heart failure New ESC Guidelines on cardiovascular management of patients undergoing non-cardiac surgery Statistics Made Easy: Part I Host: Rick Grobbee
    Guests: Sigrun Halvorsen, Paul Kalra and Emma Svennberg
    Want to watch that episode? Go to: https://esc365.escardio.org/event/758
     
    Disclaimer
    This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
    Stephan Achenbach, Rick Grobbee, Sigrun Halvorsen and Nicolle Kraenkel declared to have no potential conflict of interest to report.
    Carlos Aguiar declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
    Giuseppe Biondi-Zoccai declared to have potential conflicts of interest to report: Giuseppe Biondi-Zoccai has consulted for Balmed, Cardionovum, Crannmedical, Eukon, Innovheart, Guidotti, Meditrial, Microport, Opsens Medical, Replycare, Teleflex, and Terumo.
    Davide Capodanno declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.
    Paul Kalra declared to have potential conflicts of interest to report: Research grants: Pharmacosmos. Consultancy and lectures honoraria: Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, Pfizer, Pharmacosmos, Servier, Vifor Pharma .
    Emma Svennberg declared to have potential conflicts of interest to report: Institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme

    • 21 min
    Episode 4: Highlights of the ESC cardio-oncology guidelines - New data in renal denervation: SYMPLICITY HTN-3

    Episode 4: Highlights of the ESC cardio-oncology guidelines - New data in renal denervation: SYMPLICITY HTN-3

    ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
    This episode covers:
    Cardiology This Week: A concise summary of recent trials Highlights of the ESC Cardio Oncology Guidelines New Data in Renal Denervation: SYMPLICITY HTN-3 Mythbusters: Coffee increases the risk for heart disease Host: Rick Grobbee
    Guests: Carlos Aguiar, Teresa Lopez Fernandez and Deepak Bhatt
    Want to watch that episode? Go to: https://esc365.escardio.org/event/607
    Disclaimer:
    This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
    Stephan Achenbach, Rick Grobbee, Nicolle Kraenkel and Teresa Lopez Fernandez declared to have no potential conflict of interest to report.
    Carlos Aguiar declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
    Deepak Bhatt declared to have potential conflicts of interest to report: Research funding from Medtronic paid to Brigham and Women’s hospital for my role as co-Principal Investigator of SYMPLICITY HTN-3.
    Davide Capodanno declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.
    Emma Svennberg declared to have potential conflicts of interest to report: Institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme

    • 22 min
    Factor XIa Inhibitors: A Breakthrough in Anticoagulation? - Heart Failure Treatment: New Concepts for 2023 and Beyond

    Factor XIa Inhibitors: A Breakthrough in Anticoagulation? - Heart Failure Treatment: New Concepts for 2023 and Beyond

    ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
    This episode tackles:
    Cardiology this Week Factor XIa Inhibitors: A Breakthrough in Anticoagulation? Heart Failure Treatment: New Concepts for 2023 and Beyond Snapshots Host: Susanna Price
    Guests: Carlos Aguiar, Robert Storey, Carolyn Lam and Stephan Achenbach
    Want to watch that episode? Go to: https://esc365.escardio.org/event/602

    Disclaimer:
    This programme is intended for health care professionals only and is to be used for educational purposes.
    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
    Declarations of interests
    Stephan Achenbach, Nicolle Kraenkel, Susanna Price and Robert Storey declared to have no potential conflict of interest to report.
    Carlos Aguiar declared to have potential conflict of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
    Davide Capodanno declared to have potential conflict of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.
    Carolyn Lam declared to have potential conflict of interest to report: Carolyn S.P. Lam is supported by a Clinician Scientist Award from the National Medical Research Council of Singapore; has received research support from Bayer and Roche Diagnostics; has served as consultant or on the Advisory Board/ Steering Committee/ Executive Committee for Actelion, Alleviant Medical, Allysta Pharma, Amgen, AnaCardio AB, Applied Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Cytokinetics, Darma Inc., EchoNous Inc, Eli Lilly, Impulse Dynamics, Intellia Therapeutics, Ionis Pharmaceutical, Janssen Research & Development LLC, Medscape/WebMD Global LLC, Merck, Novartis, Novo Nordisk, Prosciento Inc, Radcliffe Group Ltd., ReCor Medical, Roche Diagnostics, Sanofi, Siemens Healthcare Diagnostics and Us2.ai; and serves as co-founder & non-executive director of Us2.ai.
    Emma Svennberg declared to have potential conflict of interest to report: Institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme

    • 22 min
    Optimal Timing of Medication / Ventricular Arrhythmias and Sudden Death Prevention

    Optimal Timing of Medication / Ventricular Arrhythmias and Sudden Death Prevention

    This episode tackles:
    Cardiology this Week TIME - The Treatment in Morning versus Evening study ESC Guidelines on ventricular arrhythmias and the prevention of sudden cardiac death Diagnostics made easy Host: Rick Grobbee
    Guests: Carlos Aguiar, Ulrich Laufs, Emma Svennberg and Jacob Tfelt-Hansen
    Want to watch that episode? Go to: https://esc365.escardio.org/event/601

    • 22 min
    The ADVOR Trial, plus the latest on TAVI durability

    The ADVOR Trial, plus the latest on TAVI durability

    ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
    This episode tackles:
    Cardiology this Week ADVOR Trial and contemporary diuretic treatment The latest on TAVI durability Mythbusters – Is eating eggs really bad for you? Want to watch that episode? Go to: https://esc365.escardio.org/event/593

    • 22 min

Classement des podcasts dans Forme et santé

Morphée
Louie Media
Anne Ghesquière
Alohalaia
Psychologue
Devibration

D’autres se sont aussi abonnés à…

American College of Cardiology
Medscape
American College of Cardiology
CardioNerds
European Society of Cardiology
Daily Cardiology Academy